BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
256 hedge funds and large institutions have $1.91B invested in BioTelemetry, Inc. in 2018 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 69 increasing their positions, 103 reducing their positions, and 24 closing their positions.
129% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 24
38% more capital invested
Capital invested by funds: $1.39B → $1.91B (+$522M)
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
13% more funds holding
Funds holding: 227 → 256 (+29)
9% more call options, than puts
Call options by funds: $27.3M | Put options by funds: $25M
33% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 103
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
+$24.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$22.8M |
| 3 |
BlackRock
New York
|
+$20.1M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$20.1M |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$43.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$33.9M |
| 3 |
N
Natixis
Paris,
France
|
-$14.4M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$12.2M |
| 5 |
LSC
Lyon Street Capital
Sausalito,
California
|
-$10.1M |
BEAT Hedge Fund Activity: Q3 2018 in Review
256 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q3 2018, worth a combined $1.91B — up 38% from $1.39B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new BEAT positions and 24 closed out — a net gain of 31 holders — while 69 added to existing stakes and 103 trimmed.
The largest buyer was Stephens Investment Management Group, opening a new position worth an estimated $24.9M. The largest seller was Glenmede Trust, exiting entirely with an estimated $43.4M sold.
- 256 institutional investors held BioTelemetry, Inc. (BEAT) as of Q3 2018, up from 227 in Q2 2018.
- Funds reported $1.91B of BioTelemetry, Inc. stock for Q3 2018, up 38% quarter-over-quarter.
- 55 funds opened new BioTelemetry, Inc. positions in Q3 2018 and 24 closed out, a net change of +31 holders.
- The largest BioTelemetry, Inc. buyer in Q3 2018 was Stephens Investment Management Group, an estimated $24.9M added.
- The largest BioTelemetry, Inc. seller in Q3 2018 was Glenmede Trust, an estimated $43.4M sold.
Based on aggregated 13F filings for Q3 2018.